Comparison between Medicap Healthcare IPO and PhonePe IPO.
Medicap Healthcare IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while PhonePe IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Medicap Healthcare IPO is up to ₹240.00 Cr whereas the issue size of the PhonePe IPO is up to ₹0.00 Cr. The final issue price of Medicap Healthcare IPO is and of PhonePe IPO is .
| Medicap Healthcare IPO | PhonePe IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹1 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ||
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹240.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 5,06,60,446 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 0 shares | 5,06,60,446 shares |
| Issue Size Total (Amount) | up to ₹240.00 Cr | up to ₹0.00 Cr |
Medicap Healthcare IPO opens on , while PhonePe IPO opens on . The closing date of Medicap Healthcare IPO and PhonePe IPO is , and , respectively.
Medicap Healthcare IPO P/E ratio is , as compared to PhonePe IPO P/E ratio of .
| Medicap Healthcare IPO | PhonePe IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Medicap Healthcare Ltd.'s revenue increased by 7% and profit after tax (PAT) rose by 11% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 98 | 73.33 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 27.30% | -18.22% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 17.67% | -26.52% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.67 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 24.02% | -18.43% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Medicap Healthcare IPO Retail Individual Investors (RII) are offered 0 shares while in PhonePe IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Medicap Healthcare IPO and 0 shares in PhonePe IPO.
| Medicap Healthcare IPO | PhonePe IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 0 shares |
| NII | 0 shares | 0 shares |
| RII | 0 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 0 shares |
Medicap Healthcare IPO subscribed in total, whereas PhonePe IPO subscribed .
